Funding
Life sciences investor MTPConnect injects $12 million into 14 drug and device startups
Not-for-profit medical products investor and accelerator MTPConnect has backed 14 Australian science companies with a combined $12.07 million to develop new devices and drugs. The funding comes from MTPConnect’s Targeted Translation Research Accelerator (TTRA) Drugs and Devices program, which is backed by the federal government’s $24 billion Medical Research Future Fund. The ideas span cardiovascular disease… Read more »
